Kymera Therapeutics, Inc. (KYMR)

80.71 -0.36 (-0.44%) USD  |  NASDAQ  |  May 01, 16:00
80.71 0.00 (0.00%) Pre-Market: 08:22
More

Kymera Therapeutics Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for KYMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Revolution Medicines, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Structure Therapeutics, Inc. Upgrade